Description
In Neuropsychological Aspects of Substance Use Disorders, internationally recognized experts provide clinicians with the most up to date information on the neuropsychology of substance use disorders based on the empirical literature. Substance use disorders continue to be a major health concern in the United States and worldwide, although their causes and effective treatments remain elusive. Research in this area has expanded dramatically over the past two decades and provided insights into psychobiological, behavioral, and genetic factors that contribute to the onset and maintenance of substance use disorders and associated neuropsychological abnormalities. This research has provided a strong empirical foundation that has direct implications for clinical neuropsychological practice and created a need to provide the practitioner with a cogent and up-to-date summary of current developments, which is the goal of this volume. Chapters in this volume are organized into three sections that are designed to provide a translational overview of basic research and treatment findings regarding addictions, neuropsychological and neurological sequalae of the most common substances of abuse, and consideration of special issues that might confound interpretation of neuropsychological test results. Section I provides an overview of addictions, including diagnoses based on the DSM-IV, as well as the most current conceptualizations of addiction from psychobiological, genetic, and behavioral and no economics perspectives, providing the reader with a broad evidence-based conceptual framework. Section II reviews the most common substances of abuse including coverage of structural and functional neuroimaging findings, epidemiological evidence, and neuropsychological sequelae. Substances included in this section represent the most commonly encountered drugs of abuse. Section III includes coverage of the number of special topics, including specific issues related to psychiatric, medical, and neurological comorbidities. Topics included in this section represent areas of common concerns faced by clinical neuropsychologists in the interpretation and application of neuropsychological test results.
Table of Contents
Preface to the National Academy of Neuropsychology Series on Evidence-Based PracticesPreface to the Third Volume in the National Academy of Neuropsychology Series on Evidence-Based PracticesContributorsChapter 1: IntroductionDaniel Allen and Steven Paul WoodsChapter 2: Neural substrates of drug abuseVeronica Bisagno and Jean Lud CadetChapter 3: Behavioral and Neuro-economic Approaches to AddictionDavid P. Jarmolowicz, Derek D. Reed, and Warren BickelChapter 4: Genetic influences on addictionAmanda Barkley-Levenson and John CrabbeChapter 5: Treatment of Addictions and Effects of Neuropsychological Impairmenton Mechanisms of Behavior ChangeMarsha Bates, Jennifer F. Buckman, and Justine C. Bates KrakoffChapter 6: Alcohol Use Disorders: Brain and Behavioral SequelaeRosemary Fama and Edith V. SullivanChapter 7: CannabisJordan Cattie and Igor GrantChapter 8: Neuropsychological sequelae of cocaine dependenceAntonio Verdejo GarcíaChapter 9: Neuropsychology of Methamphetamine Use DisordersJennifer Iudicello, Khalima Bolden, Stefanie R. Griglak, and Steven Paul Woods,Chapter 10: Club drugsJohn E. Fisk and Catherine MontgomeryChapter 11: Opioids.Olga Rass, Rebecca L. Schacht, Cherie L. Marvel, Miriam Z. Mintzer,Chapter 12: Adolescent Inhalant Misuse: Neuropsychological and Neurobiological EffectsMichael Takagi, Dan I. Lubman, Susan M. Cotton, and Murat YücelChapter 13: Neuropsychology of Serious Mental Illness and Substance Use Disorder ComorbidityDaniel N. Allen, Bern G. Lee, and Nicholas S. ThalerChapter 14: Neuropsychology of Infectious Disease and Substance Use DisordersJennifer M. Loftis, Marilyn Huckans, Erica Weber, and Steven Paul WoodsChapter 15: Substance Abuse and Traumatic Brain InjuryTresa Roebuck Spencer, Elisabeth Wilde, and Angelle SanderChapter 16: The Contribution of Neuropsychology to Functional Outcomes in Substance Use DisordersJ. Cobb Scott, Kaitlin Blackstone, and Thomas D. MarcotteChapter 17: Prescription Drug abuseKai-Hong Jeremy Mao, Lauren N. Buchheim, Jason P. CaplanChapter 18: CNS Risk Factors for and Consequences of Adolescent Substance Use on Brain Structure and FunctionSusan Tapert, Lotte Berke, Norma Castro, and Sunita BavaIndex
